20211104|IPIX|3416516|0|5763679|O 59.27% 10000 t trade/s

New Post Public Reply Private Reply Replies (2) Message Board
4kids 4kids #70735
905
20211104|IPIX| 3416516 |0| 5763679 |O 59.27%
10000 t trade/s not reflected in DRS%

make that the 11th day IPIX *marked* @ plus 50% since 10.1.21
interesting *game* NR is playing these days re: *reporting*


Quote:

I also noted to the long .. that imo NR is *under reporting* DRS%s (at least since early October) .. their go to % now is plus 50% .. imo it's closer to 70%~. And of course NR continues to *reset*. Now what is going to be interesting to observe .. is when NR (significantly upside down imo) loses *control* of IPIX.


https://investorshangout.com/post/view?id=6276755

yesterday was interesting .. not the least of being that NR *reset* the 52 week high from 50c to 54c

Open 0.47
Day High 0.54 .. *liquidity .075c*
Day Low 0.465

Previous Close
11/03/2021 0.47

52-Week High
11/04/2021 0.54

52-Week Low
11/30/2020 0.155


Price Performance (Last 52 Weeks)
11/03/2021 +95.83%


Volume 5,773,679
Volume (10 day Average) 2,088,987
Volume (90 day Average) 1,262,427


IPIX B/A @ COM 11.4.21

 
REAL-TIME LEVEL 2 QUOTE
MPID BID PRICE SIZE TIME
GTSM 0.49 23,899 15:55
ASCM 0.4889 2,500 14:09
CDEL 0.4888 3,666 15:59
ETRF 0.487 5,000 15:56
CFGN 0.481 2,500 11:53
NITE 0.481 2,500 14:50
CSTI 0.47 6,450 15:40
PUMA 0.40 2,500 15:03
OTCX 0.36 3,000 13:59
VERT 0.36 2,500 10:29
SPLN 0.122 5,000 11/30
VNDM 0.122 5,000 11/03
INTL U 0 10:18

MPID ASK PRICE SIZE TIME
NITE 0.492 7,096 15:59
GTSM 0.501 40,000 15:59
INTL 0.502 29,575 15:57
CDEL 0.51 120,018 15:59
ETRF 0.51 39,495 15:43
CSTI 0.512 10,000 15:35
CFGN 0.549 1,000 12:18
ASCM 0.5499 1,000 13:45
SPLN 0.56 1,000 01/19
VNDM 0.579 1,000 10:05
OTCX 0.589 1,000 13:45
VERT 0.589 1,000 10:29
PUMA 0.629 1,000 13:59


as for today .. NR did 90 day avg about 10 minutes into *trading*

Detailed Quote:IPIX >> 90 day avg 1.3M volume
INNOVATION PHARMACEUTICALS INC
0.37Down -0.1207 (-24.597514 %)AS OF 9:41:59AM ET 11/05/2021



NR did 10 day avg about 25 minutes into *trading*

Detailed Quote:IPIX >> 10 day avg 2.6M volume
INNOVATION PHARMACEUTICALS INC
0.375Down -0.1157 (-23.578561 %)AS OF 9:54:08AM ET 11/05/2021


as of this post (imo) NR is on track to meet or beat their 10M~ volume day from
early February (50c high effort)


Price Performance (Last 52 Weeks)
11/04/2021 +110.15%


Volume 4,898,990
Volume (10 day Average) 2,639,600
Volume (90 day Average) 1,318,956


remember IP investors .. this is an UPSIDE DOWN NR entity/entities (imo)
and NR is the master of illusion .. it's all about their ability to *control* IPIX

which works until it doesn't ..

btw @ last check .. today's *liquidity* range has already passed 15c .. think about it

what is interesting too .. if one has the time .. is to watch RT l2 .. and see
(it's happened several times this week and won't surprise me if it happens today)
if the buyer (imo NR) who literally takes out 4 to 5 MMs/ECNs on the ask
with less than 200,000 in buys .. that pattern is totally disruptive to what is usually done via *ask* (constant UCs/undercuts by the CEs/colluding entities)

i will miss most of next week (live) .. but look forward to seeing IP's execution
nothing imo beats an *aware* CEO and educated retail (OTC) investors


as always best to all IP investors ..


EDITED in .. 2 last things i forgot to note


remember NR always wants to pull in traders (or make investors .. traders)

there are 2 key price points imo in 2021 .. first was 50c (Feb reset) and the second was 375c (Jul effort)

both were *worked* this week ..

the other price point that imo matters (because it's been in play since 9/2012 re: NRs' initial cycle of money .. is 70c)

that is the price point .. i'm watching to see how *handled* ..


4kids

==========
 
20211103|IPIX| 3801012 |0| 7164866 |O 53.05%
22000 t trade not reflected in DRS %s

10th day IPIX *marked* @ plus 50% since 10.1.21
interesting *game* NR is playing these days re: *reporting*

Quote:

I also noted to the long .. that imo NR is *under reporting* DRS%s (at least since early October) .. their go to % now is plus 50% .. imo it's closer to 70%~. And of course NR continues to *reset*. Now what is going to be interesting to observe .. is when NR (significantly upside down imo) loses *control* of IPIX.


https://investorshangout.com/post/view?id=6276755




Historical Short Volume Data for IPIX

Date Close High Low Volume Sht Vol % of Vol Shtd



Nov 02 NA NA NA 3,300,305 1,964,341 59.52 *

Nov 01 NA NA NA 2,471,990 1,360,274 55.03 *

Oct 29 NA NA NA 1,031,072 413,586 40.11 ****

Oct 28 NA NA NA 2,230,533 1,669,990 74.87 ***

Oct 27 NA NA NA 666,995 444,495 66.64 **

Oct 26 NA NA NA 728,535 494,653 67.90 **

Oct 25 NA NA NA 2,184,930 1,327,875 60.77 **

Oct 22 NA NA NA 820,075 482,734 58.86 *

Oct 21 NA NA NA 267,549 145,587 54.42 *

Oct 20 NA NA NA 678,632 362,936 53.48 *

Oct 19 NA NA NA 445,416 313,754 70.44 ***

Oct 18 NA NA NA 1,033,338 678,775 65.69 **

Oct 15 NA NA NA 2,115,766 1,500,362 70.91 ***

Oct 14 NA NA NA 371,454 197,327 53.12 *

Oct 13 NA NA NA 373,098 220,809 59.18 *

Oct 12 NA NA NA 337,975 125,841 37.23 *****

Oct 11 NA NA NA 654,529 302,770 46.26 ****

Oct 08 NA NA NA 655,172 468,537 71.51 ***

Oct 07 NA NA NA 358,465 160,933 44.90 ****

Oct 06 NA NA NA 286,542 156,179 54.50 *

Oct 05 NA NA NA 651,816 147,216 22.59 --

Oct 04 NA NA NA 1,868,526 495,794 26.53 --

Oct 01 NA NA NA 3,185,969 1,876,954 58.91 *






4kids


2

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Encouraged to Join Ibotta Class Action at Gross Law Firm

Updated Category News Views 130

Investors Urged to Take Action in Ibotta Class Action Lawsuit If you have invested in Ibotta, Inc. (NYSE: IBTA), it may be time to pay attention. Shareholders are being encouraged to take part in a class action lawsuit that seeks to address the alleged wrongdoings associated with the company's public offering. This initiative is spearheaded by The Gross Law Firm, which...

Continue Reading
TOMI Environmental Solutions Welcomes Harold W. Paul to Board

Updated Category News Views 197

Strategic Board Appointment at TOMI Environmental Solutions TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a key player in the realm of disinfection and decontamination technologies, recently announced an important addition to its Board of Directors. Harold W. Paul has been appointed to this role, a move that is expected to have a significant positive impact on the...

Continue Reading
MaxCyte's Innovative Collaboration with Moonlight Bio on T Cell Therapies

Updated Category News Views 170

MaxCyte Forms Strategic Alliance with Moonlight Bio MaxCyte, Inc. (Nasdaq: MXCT), a pioneering cell-engineering organization, has recently announced a significant collaborative effort with Moonlight Bio, a Seattle-based company focused on pioneering preclinical-stage T cell therapies. This partnership will leverage MaxCyte’s advanced technologies to propel the...

Continue Reading
ZenaTech Showcases Drone Innovations and Future Strategy

Updated Category News Views 114

Revolutionizing Drone Services and Defense Innovations VANCOUVER, British Columbia — ZenaTech, Inc. (NASDAQ: ZENA) (BMV: ZENA) (FSE: 49Q) stands at the forefront of technological solutions, focusing on the exciting realm of Drone as a Service (DaaS) as well as commercial drone developments catering to various industries. The company recently announced its participation...

Continue Reading
Lavu's CEO to Share Insights on AI and Payment Innovations

Updated Category News Views 126

Lavu's CEO to Share Insights on AI and Payment Innovations Lavu, a trailblazer in restaurant AI platforms, is gearing up for an enlightening presentation featuring its CEO, Saleem S. Khatri. He will be a keynote speaker at an upcoming event focusing on the intersection of fintech, AI, and payment systems. A Discussion on Restaurant Operations and Payments The session,...

Continue Reading